News & Updates

ALXN1830, a humanized IgG4 antibody that blocks the neonatal Fc receptor (FcRn), is safe for the treatment of pemphigus in adults, reports a recent pilot trial. Aside from a good tolerability profile, ALXN1830 also induces rapid improvements in disease severity.

Cervical cancer stands out as a major concern for older women who are frequently undertreated and are at higher risk of death, a study reports.

A randomized clinical trial conducted by researchers from the Chinese University of Hong Kong (CUHK) and clinicians at Shatin Hospital and Prince of Wales Hospital in Hong Kong finds computer-assisted rapid movement training (RMT) to be as effective as conventional balance training (CBT) at improving chronic stroke survivors’ overall balance, motor function and balance recovery, indicating potential for home-based telerehabilitation.

An observational single-institution cohort study provides evidence that levetiracetam use throughout the duration of standard chemotherapy is associated with longer median overall survival (OS) in patients with isocitrate dehydrogenase (IDH) wild-type glioblastoma.

Switching to tenofovir alafenamide (TAF) from nucleos(t)ide analogue therapies was associated with improved virologic response and liver function in patients with chronic hepatitis B virus (HBV) infection, even in those with decompensated HBV cirrhosis, according to real-world studies presented at AASLD 2021.